B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL)

Clinical trials for B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL) explained in plain language.

Never miss a new study

Get alerted when new B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL) trials appear

Sign up with your email to follow new studies for B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

Custom cancer vaccine trial seeks to Re-Train immune system

Disease control Not yet recruiting

This early-stage study is testing a new, personalized mRNA vaccine (XP-006) for safety and early signs of effectiveness. It is for adults with B-cell non-Hodgkin's lymphoma that has returned or not responded to prior treatments. The vaccine is designed to teach the patient's own …

Matched conditions: B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL)

Phase: PHASE1 • Sponsor: Ruijin Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL)

Get alerted when new B-CELL NON-HODGKIN'S LYMPHOMA (B-NHL) trials appear

Custom cancer vaccine trial seeks to Re-Train immune system